Quick10K

⚲

Lingerie Fighting Championships

Filings

10-Q	2019-09-30	Filed 2019-12-06
10-Q	2019-06-30	Filed 2019-11-29
10-Q	2019-03-31	Filed 2019-05-15
10-K	2018-12-31	Filed 2019-04-16
10-Q	2018-09-30	Filed 2018-11-07
10-Q	2018-06-30	Filed 2018-09-11
10-Q	2018-03-31	Filed 2018-08-16
10-K	2017-12-31	Filed 2018-07-20
10-Q	2017-09-30	Filed 2018-03-05
10-Q	2017-06-30	Filed 2018-01-25
10-Q	2017-03-31	Filed 2017-07-06
10-K	2016-12-31	Filed 2017-06-01
10-Q	2016-09-30	Filed 2016-11-14
10-Q	2016-06-30	Filed 2016-08-15
10-Q	2016-03-31	Filed 2016-05-13
10-K	2015-12-31	Filed 2016-04-14
10-Q	2015-09-30	Filed 2015-11-13
10-Q	2015-06-30	Filed 2015-08-14
10-Q	2015-03-31	Filed 2015-05-20
10-K	2015-02-28	Filed 2015-06-03
10-Q	2014-11-30	Filed 2015-01-14
10-Q	2014-08-31	Filed 2014-10-09
10-Q	2014-05-31	Filed 2014-07-09
10-K	2014-02-28	Filed 2014-05-29
10-Q	2013-11-30	Filed 2014-01-17
10-Q	2013-08-31	Filed 2013-10-18
10-Q	2013-05-31	Filed 2013-07-16
10-K	2013-02-28	Filed 2013-06-13
10-Q	2012-11-30	Filed 2013-01-22
10-Q	2012-08-31	Filed 2012-10-19
10-Q	2012-05-31	Filed 2012-07-23
10-K	2012-02-29	Filed 2012-07-10
10-Q	2011-11-30	Filed 2012-01-23
10-Q	2011-08-31	Filed 2011-10-24
10-Q	2011-05-31	Filed 2011-07-19
10-K	2011-02-28	Filed 2011-06-15
10-Q	2010-11-30	Filed 2011-01-19
10-Q	2010-08-31	Filed 2010-10-19
10-Q	2010-05-31	Filed 2010-07-20
10-K	2010-02-28	Filed 2010-07-19
10-Q	2009-11-30	Filed 2010-02-12

Reports

8-K	2018-03-28
8-K	2018-03-05

Lingerie Fighting Championships Financials

BOTY Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin


Comps ($'000 TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI)				0%	1,546,418	322,654	0	0	0	0	-853,740
1 800 Flowers Com (FLWS)	944,324	42%	13.3	6%	664,955	335,559	1,266,390	533,727	36,761	75,090	1,000,932
10x Genomics (TXG)	4,804,979	75%	-490.3	-2%	572,815	151,367	61,207	45,727	-9,603	-8,887	4,357,180
12 Retech (RETC)	0	32%	-0.1	-1,385%	1,118	20,421	625	199	-15,491	-14,800	966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH)	33,711	0%	0.4	-5%	164,088	108,405	18,194	0	-7,969	-8,017	-2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH)		25%	-2.4	-15%	18,527	23,194	27,219	6,699	-2,862	-1,433	3,396
1895 Bancorp of Wisconsin (BCOW)	46,152,715		12,508.1	-0%	441,187	382,722	0	0	-44	3,689	46,142,359
1st Constitution Bancorp (FCCY)	164,504	0%	4.4	1%	1,342,565	1,204,038	490	0	13,787	32,503	143,748
1st Franklin Financial (FFC)	3,551		-0.6	7%	905,107	644,730	0	0	62,078	80,004	-45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE)	1,200,033		7.9	1%	6,691,070	5,858,028	0	0	70,061	136,342	1,072,548
2050 Motors (ETFM)	0		-0.2	-166,272,400%	0	1,849	0	0	-1,663	-1,654	250
21Vianet Group (VNET)	6,005,116			0%	11,150,717	5,787,533	0	0	0	0	3,344,095
22nd Century (XXII)	301,854	1%	-14.1	-36%	61,864	6,554	25,706	304	-22,433	-21,464	301,826
1Life Healthcare (ONEM)


Balance Sheet ($'000)	2011-11-30	2012-02-29	2012-05-31	2012-08-31	2012-11-30	2013-02-28	2013-05-31	2013-08-31	2013-11-30	2014-02-28	2014-05-31	2014-08-31	2014-11-30	2015-02-28	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	2	5	1	63	16	6	12	4	61	36	19	3	2	4	7	117	26	22	10	22	50	58	32	1	0	28	10	1	34	3	102	28	2
Accounts Receivable	91	40	22														15
Inventory		6	9
PP&E	96	92	85	0	0	0
Assets	583	471	388	147	58	6	12	4	61	36	19	3	2	4
Accounts Payable	137	72	43
Long-Term Debt	0
Liabilities	2,032	2,194	2,381	1,031	183	226	118	158	177	215	247	270	8	42
Stockholders' Equity						-220	-106	-154	-115	-180	-228	-267	-6	-39	153	117	25	-16	-21	-324	-550	-1,232	-1,099	-1,147	-1,590	-2,455	-3,855	-2,375	-2,714	-2,255	-2,342	-2,551	-2,555


Income Statement ($'000)	2011-11-30	2012-02-29	2012-05-31	2012-08-31	2012-11-30	2013-02-28	2013-05-31	2013-08-31	2013-11-30	2014-02-28	2014-05-31	2014-08-31	2014-11-30	2015-02-28	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	34	73	39	0	0	0	0	0	0	0	0	0				0	19	-13	1	3	15	50		10	6	0	2	2	9		1	2	19
Cost of Revenue	180	16	18	0	0	0										14	30	-11	0	41	11	54	21	6	19	8	20	1	2		0	11	22
Gross Profit	-147	57	21	0	0	0										-14	-11	-2	1	-38	4	-4	-21	3	-13	-8	-19	0	6		1	-9	-3
R&D
SG&A	365	368	300	125	92	82	86	48	62	64	48	39	9	40	15	31	81	44	6	78	85	264	97	59	57	42	78	49	57		55	82	45
Tax	-0	3	3	0	0	0	0	0	0	0	0	0			0	-0	0	0			0		0	0		0	0		0		0	0	0
Net Income	-691	-313	-282	-125	-184		-86	-48	-62	-64	-48	-39	-9	-32	-21	-44	-92	-41	-5	-203	-256	-1,339	-63	-48	-579	-867	-1,431	1,480	-350		-99	290	-102


Cash Flow ($'000)	2011-11-30	2012-02-29	2012-05-31	2012-08-31	2012-11-30	2013-02-28	2013-05-31	2013-08-31	2013-11-30	2014-02-28	2014-05-31	2014-08-31	2014-11-30	2015-02-28	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating		-173	-166	-83	-22	-10	-69	-7	-43	-26	-17	-16		-34	-5	-54	-91	-4	-12	-132	-52	-53	-71	-31		-61	-68		-47		-17		-26
Cash Investing		-9	0	0	0	0	0								3	0	0	0											0		0	0
Cash Financing		186	162	150	-25	0	75	0	100	0	0	0			5	164	0	0	-0	144	80	60	45	0		87	50		80		116		0